Researchers at Mayo Clinic found unique molecular signatures of blood-brain barrier dysfunction in Alzheimer's disease, potentially leading to new diagnostic and treatment methods.

Researchers at Mayo Clinic discovered unique molecular signatures of blood-brain barrier dysfunction in Alzheimer's disease. These signatures, published in Nature Communications, could lead to new ways to diagnose and treat the disease. The blood-brain barrier, essential for nourishing and protecting the brain, is disrupted in Alzheimer's, and these new findings highlight potential novel biomarkers to capture brain changes in the condition.